Home | MyCME | All CME | Blog | Psychlopedia

Series Home Page

Easing the Burden of Treatment-Resistant Depression

Maurizio Fava, MD (Chair)

Find out about risk factors for treatment resistance, and learn pharmacotherapeutic strategies to optimize your patients' medication regimens to help them achieve remission.

Supported by an educational grant from Bristol-Myers Squibb Company and Otsuka America Pharmaceutical, Inc.

  • Family Problems Among Recently Returned Military Veterans Referred for a Mental Health Evaluation/Effectiveness of Brief Cognitive-Behavioral Therapy for Schizophrenia Delivered by Mental Health Nurses: Relapse and Recovery at 24 Months/Easing the Burden of Treatment-Resistant Depression/New Developments in the Treatment of Alzheimer’s Disease

    Steven L. Sayers, Victoria A. Farrow, Jennifer Ross, and David W. Oslin / Navdeep Malik, David Kingdon, Jeremy Pelton, Raj Mehta, and Douglas Turkington / Maurizio Fava, MD (Chair), et al / Peter V. Rabins, MD, MPH (Chair), et al

    Harvard Medical School and Massachusetts General Hospital, Boston

  • Partial Responders to Antidepressant Treatment: Switching Strategies

    Maurizio Fava, MD

    Harvard Medical School and Massachusetts General Hospital, Boston

  • Augmentation and Combination Strategies in Resistant Depression

    J. Craig Nelson, MD

    University of California School of Medicine, San Francisco

  • Treating Depression to Full Remission

    Madhukar H. Trivedi, MD

    University of Texas Southwestern Medical Center, Dallas

  • Evaluating Atypical Antipsychotics in the Treatment of Refractory Depression

    Michael E. Thase, MD

    University of Pennsylvania School of Medicine, the Philadelphia Veterans Affairs Medical Center, and the University of Pittsburgh Medical Center, Philadelphia and Pittsburgh, Pa